chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Diarrhoea, Pain in extremity
Clinical narrative: I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; left arm soreness onset evening of vaccine for about 1.5 days; This is a spontaneous report from a contactable nurse (also the patient). A 51-year-old female (also the age at vaccination) patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3248), via an unspecified route of administration at the left arm on 07Jan2021 14:40 (also reported as 02:45 PM) at SINGLE DOSE for Covid-19 immunization. The patient was vaccinated at a Hospital. The patient is not pregnant at the time of the report. Medical history included Environmental allergies: some trees and grass (also reported as Known allergies: No). The patient had no COVID prior to vaccination. Th patient was not COVID tested post vaccination. No other vaccine in four weeks. Concomitant medication included (reported as Other medications in two weeks) bupropion hydrochloride (WELLBUTRIN), loratadine, pseudoephedrine sulfate (CLARITIN-D), montelukast sodium (SINGULAIR), diphenhydramine hydrochloride (BENADRYL), vitamin d nos (VITAMIN D NOS) and MVM (exact meaning unspecified). It was reported that: "Administration time on my paperwork was documented incorrectly; I received 07Jan2021 dose at 2:40pm and not the 1:40pm time that is documented. I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration (reported as 5:30 PM), lasting about 2 hours and resolved; left arm soreness onset evening of vaccine for about 1.5 days." The patient was not treated for the events. The outcome of the events was recovered.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Fatigue, Hypersomnia, Off label use
Clinical narrative: has been on immunotherapy for lung cancer; has been on immunotherapy for lung cancer; off-balance weakness/off-balance; off-balance weakness; feeling tired/fatigue; sleeping a lot; This is a spontaneous report from a contactable consumer (patient's wife). A male patient (husband) of an unspecified age (Age: 78, Units: Unknown) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included the patient had been on immunotherapy for lung cancer for almost a year and it had been working and shrinking everything; took the chemo prior but stopped because of his feet as it gave him neuropathy so he only took 3; and neuropathy (he was fantastic prior to the shot with the only symptom being his feet neuropathy). Historical vaccine included first dose of BNT162B2 on an unspecified date for COVID-19 immunization (took the first dose of Pfizer COVID-19 vaccine and he was fine). The reported stated after the patient's second dose (unspecified date), he was feeling tired and sleeping a lot since this past Saturday (30Jan2021). Upon recent follow-up, the reporter asked if how long side effects last and if anyone had a reoccurrence of symptoms. The reporter was calling regarding her husband who had the second dose of vaccine and the patient had symptoms: fatigue and tiredness and it went away in a day and a half, but then he had a reoccurrence, after 2-3 days. On 04Feb2021, the patient had off-balance weakness. Yesterday morning (04Feb2021), he got up and was really off-balance. The nurse said it should subside in 1-2 days, and it did but then he had a reoccurrence. She stated he had been on immunotherapy for lung cancer for almost a year and it had been working and shrinking everything. The patient received the vaccine at (name) in (state name). The caller asked if there was an interaction with the immunotherapy and the vaccine. And also, asked if the patient should have not gotten the vaccine. She stated she will call the doctor after the call. The caller stated at the nursing home, not one person had a reaction with the second shot. The outcome of the events feeling tired/fatigue, sleeping a lot, and "off balance weakness" was not recovered.  Information about Lot/Batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Product use issue
Clinical narrative: has been on immunotherapy for lung cancer; has been on immunotherapy for lung cancer; off-balance weakness/off-balance; off-balance weakness; feeling tired/fatigue; sleeping a lot; This is a spontaneous report from a contactable consumer (patient's wife). A male patient (husband) of an unspecified age (Age: 78, Units: Unknown) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included the patient had been on immunotherapy for lung cancer for almost a year and it had been working and shrinking everything; took the chemo prior but stopped because of his feet as it gave him neuropathy so he only took 3; and neuropathy (he was fantastic prior to the shot with the only symptom being his feet neuropathy). Historical vaccine included first dose of BNT162B2 on an unspecified date for COVID-19 immunization (took the first dose of Pfizer COVID-19 vaccine and he was fine). The reported stated after the patient's second dose (unspecified date), he was feeling tired and sleeping a lot since this past Saturday (30Jan2021). Upon recent follow-up, the reporter asked if how long side effects last and if anyone had a reoccurrence of symptoms. The reporter was calling regarding her husband who had the second dose of vaccine and the patient had symptoms: fatigue and tiredness and it went away in a day and a half, but then he had a reoccurrence, after 2-3 days. On 04Feb2021, the patient had off-balance weakness. Yesterday morning (04Feb2021), he got up and was really off-balance. The nurse said it should subside in 1-2 days, and it did but then he had a reoccurrence. She stated he had been on immunotherapy for lung cancer for almost a year and it had been working and shrinking everything. The patient received the vaccine at (name) in (state name). The caller asked if there was an interaction with the immunotherapy and the vaccine. And also, asked if the patient should have not gotten the vaccine. She stated she will call the doctor after the call. The caller stated at the nursing home, not one person had a reaction with the second shot. The outcome of the events feeling tired/fatigue, sleeping a lot, and "off balance weakness" was not recovered.  Information about Lot/Batch number has been requested.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Body temperature increased, Chills, Diarrhoea
Clinical narrative: diarrhea; injection site pain; tiredness; headache; muscle pain; chills with elevated temp; chills with elevated temp; joint pain; injection site swelling and redness; injection site swelling and redness; nausea; feeling unwell; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9265), via an unspecified route of administration at the left arm on 28Jan2021 at 08:00 AM (at age of 83 years old) at a single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The facility where the most recent COVID-19 vaccine was administered was reported as "Other". The patient's medical history included stage 3 kidney, prediabetes, and allergies to sulfa. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received unspecified concomitant medications (patient received other medications within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took hypromellose (GENTEAL; reported as "gen-teal") and experienced allergy. On 29Jan2021 at 02:00 AM, the patient experienced diarrhea, injection site pain, tiredness, headache, muscle pain, chills with elevated temp, joint pain, injection site swelling and redness, nausea, and feeling unwell. The patient did not receive treatment for the events. The patient has not been tested for COVID-19 since the vaccination. The events were reported as non-serious. The outcome of the events was recovering.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Myalgia, Nausea
Clinical narrative: diarrhea; injection site pain; tiredness; headache; muscle pain; chills with elevated temp; chills with elevated temp; joint pain; injection site swelling and redness; injection site swelling and redness; nausea; feeling unwell; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9265), via an unspecified route of administration at the left arm on 28Jan2021 at 08:00 AM (at age of 83 years old) at a single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The facility where the most recent COVID-19 vaccine was administered was reported as "Other". The patient's medical history included stage 3 kidney, prediabetes, and allergies to sulfa. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received unspecified concomitant medications (patient received other medications within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took hypromellose (GENTEAL; reported as "gen-teal") and experienced allergy. On 29Jan2021 at 02:00 AM, the patient experienced diarrhea, injection site pain, tiredness, headache, muscle pain, chills with elevated temp, joint pain, injection site swelling and redness, nausea, and feeling unwell. The patient did not receive treatment for the events. The patient has not been tested for COVID-19 since the vaccination. The events were reported as non-serious. The outcome of the events was recovering.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: diarrhea; injection site pain; tiredness; headache; muscle pain; chills with elevated temp; chills with elevated temp; joint pain; injection site swelling and redness; injection site swelling and redness; nausea; feeling unwell; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9265), via an unspecified route of administration at the left arm on 28Jan2021 at 08:00 AM (at age of 83 years old) at a single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The facility where the most recent COVID-19 vaccine was administered was reported as "Other". The patient's medical history included stage 3 kidney, prediabetes, and allergies to sulfa. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received unspecified concomitant medications (patient received other medications within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took hypromellose (GENTEAL; reported as "gen-teal") and experienced allergy. On 29Jan2021 at 02:00 AM, the patient experienced diarrhea, injection site pain, tiredness, headache, muscle pain, chills with elevated temp, joint pain, injection site swelling and redness, nausea, and feeling unwell. The patient did not receive treatment for the events. The patient has not been tested for COVID-19 since the vaccination. The events were reported as non-serious. The outcome of the events was recovering.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Cough, Headache, Myalgia
Clinical narrative: Sore throat; chills; headache; lower back pain; muscle pain; sinus drainage; severe cough; This is a spontaneous report from a contactable consumer (patient).  A 64-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL9262), via an unspecified route of administration on the right arm on 27Jan2021 09:30 at a single dose for COVID-19 immunisation.  Medical history included hypertension. The patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan, atenolol, and atorvastatin. The patient experienced sore throat, chills, headache, lower back pain, muscle pain, severe cough with thick yellow phlegm on 29Jan2021 13:00. It was reported that the patient had sinus drainage on 29Jan2021 13:00.  There was no treatment for the events. The patient has not recovered from the events yet.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Paranasal sinus hypersecretion
Clinical narrative: Sore throat; chills; headache; lower back pain; muscle pain; sinus drainage; severe cough; This is a spontaneous report from a contactable consumer (patient).  A 64-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL9262), via an unspecified route of administration on the right arm on 27Jan2021 09:30 at a single dose for COVID-19 immunisation.  Medical history included hypertension. The patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan, atenolol, and atorvastatin. The patient experienced sore throat, chills, headache, lower back pain, muscle pain, severe cough with thick yellow phlegm on 29Jan2021 13:00. It was reported that the patient had sinus drainage on 29Jan2021 13:00.  There was no treatment for the events. The patient has not recovered from the events yet.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Lip tingling/fizzing; This is a spontaneous report from a contactable nurse (patient).  A 42-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 3246), via an unspecified route of administration (at the age of 42-years-old) on 21Jan2021 10:00 at a single dose in right arm for COVID-19 immunization. Medical history included none. No allergies to medications, food, or other products. Concomitant medication included rosuvastatin calcium (CRESTOR), spironolactone, tacrolimus, and macrogol 3350 (MIRALAX). The patient experienced lip tingling/fizzing on 28Jan2021 19:00 with outcome of recovering. No treatment received for the adverse event. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The event was considered as non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site/arm soreness/just the area around the needle site/Just tender; This is a spontaneous report received from a Pfizer-sponsored program, Pfizer First Connect. A contactable consumer (reported for herself) reported that a female patient of an unspecified age (age: 82; unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 30Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Jan2021, the patient mentioned "injection site/arm soreness". The patient said it was just the area around the needle site. Just tender. It was not extremely sire, it was tender sore. The patient was asking if how she would know if they will get a hematoma after the vaccine and if she should expect anything and the patient was made aware of signs of potential hematoma with redness, swelling, pain or bruising. The patient was referred to speak with healthcare professional (HCP) if she believes there is a hematoma or concerns about potential hematoma forming. The outcome of the event was unknown.  Information on the Lot/Batch number has been requested.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Photopsia, Vision blurred
Clinical narrative: the onset of blurred vision in one eye and flashing colored lights in both eyes.; the onset of blurred vision in one eye and flashing colored lights in both eyes.; This is a spontaneous report from a contactable physician (patient). A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), intramuscular at the left arm on 21Jan2021 08:45 at single dose for COVID-19 immunization. Medical history included Parkinson's and neuropathy. The patient has allergies to CIPRO antibiotics. Concomitant medication included unspecified multiple supplements. On 22Jan2021 at 09:00 (24 hours after vaccination), the patient had the onset of blurred vision in one eye and flashing colored lights in both eyes. This was unlike anything he has ever experienced, and it persisted for several hours. Vision gradually returned to normal and lights disappeared. This was not a retinal detachment or vitreous detachment. It was not associated with eye pain. The patient did not receive any treatment for the events. The patient recovered from the events on an unspecified date in 2021.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: just a sore arm starting approx 6 hours after injection; This is a spontaneous report from a contactable healthcare professional (patient). A 51-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL3249; expiration date: unknown) at vaccination age of 51-year-old intramuscular in the right arm on 15Jan2021 10:00 at a single dose for covid-19 immunization. Medical history included high blood pressure, and allergies to penicillin and sulfa. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included unspecified medication. The patient received her most recent COVID-19 in a public health clinic/veterans administration facility. The patient reported that she did no adverse events, she was just a sore arm starting approximately 6 hours after injection (15Jan2021) and lasting about 24 hours (16Jan2021). The event was non-serious. The patient has not been tested for COVID-19 since the vaccination. The outcome of the event was recovered on 16Jan2021.  No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing
Clinical narrative: Face flush for 6 hours; This is a spontaneous report from a non-contactable consumer. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose, lot number and expiration date unknown, via an unspecified route of administration at the age of 67 years on 25Jan2021 11:30 at single dose in the left arm for COVID-19 immunization. Medical history included mild hypertension. The patient had no allergies to medications, food, or other products. Prior vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included rosuvastatin, losartan and hctz. The patient experienced face flush (non-serious) for 6 hours on 25Jan2021 11:45. There was no treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not been tested for COVID-19 since vaccination. The outcome of the event was recovered.  No follow-up attempts are possible, information about batch number cannot be obtained.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, SARS-CoV-2 test, Vaccination site pain, Vaccination site swelling
Clinical narrative: Headache; Pain at injection site; Swollen injection site; Fatigued; This is a spontaneous report from a contactable consumer (patient). A 30 -year-old male patient received his  first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9626), via an unspecified route of administration (on the left arm) on 30Jan2021 16:15 (at the age of 30-years-old), single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included amlodipine;olmesartan, lorazepam. The patient experienced Headache,Pain at injection site, Swollen injection site, Fatigued, all on 31Jan2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 06Jan2021 Nasal Swab (reported as post vaccination). No treatment received for the adverse events. The outcome of the events was not recovered. Prior to vaccination, it is unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 (date of test reported as 06Jan2021). The reporter assessed the events as non-serious.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This is a spontaneous report from a contactable consumer (patient herself). A 47-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL 9262, expiration date was unknown), via an unspecified route of administration on 26Jan2021 at 08:30 AM at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was reported as the hospital. The patient's medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Jan2021 at 11:00 AM, the patient experienced fever. The patient assessed the event as non-serious. The patient did not receive any treatment for the adverse event. The patient was not recovered from the event.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Sciatica
Clinical narrative: sciatic nerve diagnosed as inflamed only left leg and shot provided left arm; This is a spontaneous report from a contactable nurse (patient). A 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration in right arm on 08Jan2021 14:00 at a single dose for Covid-19 immunization. Medical history included blood pressure. Concomitant medication included unspecified blood pressure medication. On 09Jan2021 at 2pm, sciatic nerve was diagnosed as inflamed only on left leg and shot (treatment) was provided in left arm. Patient visited emergency room/department, methylprednisolone sodium succinate (PF) was given as treatment. The event was reported as non-serious, patient was not hospitalized. The patient underwent lab tests which included COVID-19 Nasal RT-PCR: negative on 25Jan2021 (Nasal Swab). Outcome of the event was recovering.    Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Hyperhidrosis, Vaccination site erythema
Clinical narrative: Right arm remains red; Sweats profusely; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (BNT162B2; Lot number and expiry date not reported) via an unspecified route of administration to right arm from 15Jan2021 at 09:00 at single dose for covid-19 immunization. Medical history included arthritis from an unknown date. There were no concomitant medications. The patient experienced Right arm remains red and sweats profusely on 17Jan2021 at 12:00 AM. The events were reported as non-serious. No treatments were received for the reported events. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: the vision in my right eye became blurry; This is a spontaneous report from a contactable consumer (patient herself). A 78-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el9262), via an unspecified route of administration in the left arm on 26Jan2021 09:00 at a single dose for COVID-19 immunization. The patient had no relevant medical history and no known allergies. Concomitant medication included metoprolol succinate (TOPROL 25 mg) received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el3246), via an unspecified route of administration in the left arm on 05Jan2021 11:30 for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. She was not pregnant. The patient experienced "the vision in my right eye became blurry" on 26Jan2021 09:15. The patient reported that the event was "still is" as date of the report. The event was reported as non-serious and resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered. The patient had not been tested for COVID-19 since the vaccination.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash macular
Clinical narrative: sudden rash appear on left side of my chest and shoulder, just visually a bunch of red dots; Swollen lymph nodes, both collar bone and neck; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via an unspecified route of administration at the left arm on 26Jan2021 at single dose for COVID-19 immunisation. The patient has no medical history. The patient was not pregnant at the time of vaccination. Concomitant medication included ethinylestradiol, levonorgestrel (LUTERA). The patient experienced swollen lymph nodes, both collar bone and neck noticed the evening of 30Jan2021. Expected as much for an immune response, but then she had a sudden rash appear on left side of her chest and shoulder, just visually a bunch of red dots, no itching or discomfort the afternoon of 31Jan2021. She was reporting immediately, so no recovery yet. The patient did not receive any treatment for the events. The patient has not recovered from the events.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain, Pain in extremity
Clinical narrative: experience left arm pain radiating from my shoulder down to my fingers; experience left arm pain radiating from my shoulder down to my fingers; left arm weakness; This is a spontaneous report from a contactable physician (patient). A 65-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EJUe85; expiration date: unknown) at vaccination age of 65-year-old intramuscularly in the left arm on 20Jan2021 10:30 at a single dose for covid-19 immunization. The patient's medical history was none. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has no allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EJUe85) at vaccination age of 65-year-old intramuscularly in the left arm on 30Dec2020 at a single dose for covid-19 immunization. The patient received the most recent COVID-19 vaccine in a hospital. On 21Jan2021 after the second Pfizer dose (24 hours after the injection), she began to experience left arm pain radiating from her shoulder down to her fingers. The pain was sharp, constant and associated with left arm weakness. This has persisted for 10 days with no relief and she was still experiencing this pain now. The events were considered as non-serious and did not require treatment. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was not recovered.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Eye pain, SARS-CoV-2 test
Clinical narrative: dizziness; achiness behind my eyes for 16 days; This is a spontaneous report from a contactable healthcare professional (patient). A 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), via an unspecified route of administration at the left arm on 14Jan2021 at 12:30 PM at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was a hospital. The patient was not pregnant at the time of vaccination. The patient's medical history included penicillin allergy.  There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162B2 (lot number: EK5730) on 26Dec2020 at 03:30 PM (at the age of 45 years old) at the left arm for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. On 16Jan2021 at 09:00 AM, the patient experienced dizziness and achiness behind her eyes for 16 days. The patient did not receive treatment for the events. The events were reported as non-serious. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient has been tested for COVID-19 which included Nasal Swab: Negative on 31Jan2021.  The outcome of the events was not recovered.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspepsia, Headache, Nausea
Clinical narrative: Nausea/feel like vomiting-riding bike in esophagus; indigestion; diarrhea; Slight headache on injection day; This is a spontaneous report from a contactable consumer reporting for himself. A 65-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the right arm on 30Jan2021 08:30 AM at single dose for COVID-19 immunization in a hospital. Medical history included hypertension, anxiety and penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified medications received within two weeks of vaccination. The patient experienced slight headache on injection day. The patient experienced nausea and indigestion leading to diarrhea and feel like vomiting - riding bike in esophagus on 31Jan2021 at 01:00 AM. The patient did not receive any treatment for the events. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Pain
Clinical narrative: pain; inflammation,; This is a spontaneous report from a Pfizer-sponsored program, received from a contactable consumer, reporting for herself. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 29Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pain and inflammation. She was concerned about taking Advil and/or Tylenol after her surgery on Monday. She has not taken those medications yet, however, she asked if taking them for any pain or inflammation, could that interfere with the immunization process of her vaccination. The outcome of the events was unknown.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vertigo, Vomiting
Clinical narrative: Vomiting; vertigo; headache; This is a spontaneous report from a contactable patient (consumer).  female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on the left arm, at age 37 years, first dose on an unspecified date, at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced vomiting, vertigo and headache on 31Jan2021 10:00. Facility where the most recent COVID-19 vaccine was administered was at a Administration facility. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Treatment was not received for the adverse event. Since the vaccination, the patient has nor been tested for COVID-19. The outcome of the event was not recovered. Case was reported as non-serious.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Fatigue, Headache
Clinical narrative: chills; congestion; achiness; runny nose; pain around the sinuses; fever; cough; tired; low appetite; sneezing; headache; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 18Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient developed symptoms 11 days after her first dose. On 29Jan2021, she reported Chills, Congestion, Achiness, Runny nose, Pain around the Sinuses, Fever, Cough, Tired, Low appetite, Sneezing and Headache. The patient wanted to know if these side effects were reported with Pfizer Covid-19 vaccine. The patient also asked if she can I still develop COVID-19 infection after receiving the first dose. Also, if the vaccine cause a false positive COVID-19 test. She also asked what was the timing of the 2nd dose of vaccine and if she can get the second dose 21 days after dose 1. The patient also asked if both doses of Pfizer COVID-19 vaccine are identical. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pain, Pyrexia, Rhinorrhoea, Sinus pain
Clinical narrative: chills; congestion; achiness; runny nose; pain around the sinuses; fever; cough; tired; low appetite; sneezing; headache; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 18Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient developed symptoms 11 days after her first dose. On 29Jan2021, she reported Chills, Congestion, Achiness, Runny nose, Pain around the Sinuses, Fever, Cough, Tired, Low appetite, Sneezing and Headache. The patient wanted to know if these side effects were reported with Pfizer Covid-19 vaccine. The patient also asked if she can I still develop COVID-19 infection after receiving the first dose. Also, if the vaccine cause a false positive COVID-19 test. She also asked what was the timing of the 2nd dose of vaccine and if she can get the second dose 21 days after dose 1. The patient also asked if both doses of Pfizer COVID-19 vaccine are identical. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: chills; congestion; achiness; runny nose; pain around the sinuses; fever; cough; tired; low appetite; sneezing; headache; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 18Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient developed symptoms 11 days after her first dose. On 29Jan2021, she reported Chills, Congestion, Achiness, Runny nose, Pain around the Sinuses, Fever, Cough, Tired, Low appetite, Sneezing and Headache. The patient wanted to know if these side effects were reported with Pfizer Covid-19 vaccine. The patient also asked if she can I still develop COVID-19 infection after receiving the first dose. Also, if the vaccine cause a false positive COVID-19 test. She also asked what was the timing of the 2nd dose of vaccine and if she can get the second dose 21 days after dose 1. The patient also asked if both doses of Pfizer COVID-19 vaccine are identical. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea/ Stools loose; This is a spontaneous report from a contactable consumer (patient). A 90-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318), via an unspecified route of administration into the left arm on 30Jan2021 13:00 at a single dose for COVID-19 immunisation. Medical history included metastatic thyroid cancer and ventilator/oxygen/feeding tube dependent. Patient was not pregnant. Concomitant medication included metoprolol (METOPROLOL), furosemide (LASIX), valacyclovir (VALACYCLOVIR), bifidobacterium lactis (PROBIOTIC) and cetirizine hydrochloride (CETIRIZ). On 30Jan2021 13:30, patient experienced diarrhea; also reported as stools loose. The event was reported as non-serious and the patient was treated with loperamide. Outcome of event was recovering.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Faeces discoloured, Nervousness
Clinical narrative: very active stomach, diarrhea due to problem (nervous)/bowel movement really often; very active stomach, diarrhea due to problem (nervous)/bowel movement really often; Stool being dark is concerning; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received second dose of bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot EL8982), intramuscular in right arm on 29Jan2021 at SINGLE DOSE for Covid-19 immunisation. Medical history included high blood pressure and had insulin resistance. She had her first dose of BNT162B2 on 03Jan2021. Concomitant medication included metformin. She also mentioned 'Candistan Clotrimazole' (not clear nor clarified) something like that, and also took 'Premarin' (not clear nor clarified) it's hormone for menopause. She got the vaccine instead of 21 days it was 26 days. Since when she had the vaccine, her stomach was really active, diarrhea due to problem (nervous). She informed having bowel movements like really often. Today (Jan2021), she already went twice but the thing was she was going and it was like too dark, mentioned that stool being dark was concerning.  She took Libertrim S11 Trimebutine Simethicone, for diarrhea. The outcome of events was unknown.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: slight fatigue the next day; some left arm soreness; This is a spontaneous report from a contactable consumer (reported for himself). A 79-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot EL 9261, expiry date not reported), via an unspecified route of administration on 21Jan2021 at a single dose in the left arm for COVID-19 immunization. Medical history included high blood pressure, a-fib, small stroke 5 years ago and some weakness from that (stroke). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included atenolol, amlodipine, warfarin, and lisinopril. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in the hospital. On 26Jan2021, patient experienced slight fatigue the next day (as reported) and some left arm soreness. No treatments received in response to the events reported. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events fatigue and left arm soreness was recovered in Jan2021.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Headache, Pain in extremity
Clinical narrative: Fever over 100; headache; chills; joint soreness; arm soreness; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9264, expiration date was not reported), via an unspecified route of administration on the left arm on 30Jan2021 14:00 at single dose for COVID-19 immunization. Medical history included Sulfa allergy, penicillin allergy, COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included estradiol. The patient experienced fever over 100, headache, chills, joint soreness and arm soreness on 31Jan2021 at 04:00 am. No treatment was given in response to the events. Outcome of the events was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever over 100; headache; chills; joint soreness; arm soreness; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9264, expiration date was not reported), via an unspecified route of administration on the left arm on 30Jan2021 14:00 at single dose for COVID-19 immunization. Medical history included Sulfa allergy, penicillin allergy, COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included estradiol. The patient experienced fever over 100, headache, chills, joint soreness and arm soreness on 31Jan2021 at 04:00 am. No treatment was given in response to the events. Outcome of the events was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Joint range of motion decreased, Pain in extremity, Paraesthesia
Clinical narrative: headache on right side of head; back went out from right side and cannot bend over; right leg hurts; right foot tingles; This is a spontaneous report from a contactable other healthcare professional (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3246) via an unspecified route of administration on the right arm on 29Jan2021 10:00 at a single dose for COVID-19 immunization. Medical history included patient diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 06Jan2021 for COVID-19 immunization (lot number: EK4176, administration time: 02:00 PM on left arm). The patient previously took levofloxacin (LEVAQUIN) and cefalexin (KEFLEX) and experienced allergies to medications. On 30Jan2021 10:00 PM, the patient experienced headache on right side of head, back went out from right side and cannot bend over, right leg hurts and right foot tingles. No fever. No treatment was received for the adverse events. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The facility where the vaccine was administered was in a hospital. Patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovering.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: joint pain in his big toe on his left foot; This is a spontaneous report from a contactable consumer (patient himself). A 77-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL9262, NDC/UPC number and expiry date were unknown), via an unspecified route of administration in the left deltoid (also reported as the left shoulder) on 29Jan2021 at 09:30 AM at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was reported as the public health clinic/veterans administration facility. Relevant medical history included sleep problem. The patient had no allergies to medications, food, or other products. Concomitant medication included promethazine (strength: 25 mg) for sleep problem. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had the Pfizer COVID vaccine shot on Friday morning, on 29Jan2021, and later that day by the evening, he started to experience some joint pain in his big toe on his left foot and the pain had not changed or gone away since then. The patient assessed the event as non-serious. The adverse event did not require any visit to the physician office or emergency room. The patient further stated that he haven't done anything. It happened on Friday and it was there the day prior reporting (yesterday), and it was there in the morning at the time of the report, and the patient was just kind of waiting to see if it would get any better. So, he haven't done anything and was asking what he should do about that. Therapeutic measures were taken as a result of joint pain in his big toe on his left foot, which included that the patient took some paracetamol (TYLENOL), but it didn't really seem to help much, so he didn't take anymore. The patient had no investigation assessment. The patient was not recovered from the event.